Literature DB >> 10915724

Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases.

M P Bralet1, J M Régimbeau, P Pineau, S Dubois, G Loas, F Degos, D Valla, J Belghiti, C Degott, B Terris.   

Abstract

Hepatocellular carcinoma (HCC) occurring in nonfibrotic liver represents a rare, ill-defined subgroup of HCC without cirrhosis in which mechanisms of hepatocarcinogenesis remain unclear. The aim of our study was to assess epidemiological factors and detailed histopathologic changes in the nontumoral liver of patients developing such tumors. Of 330 HCCs resected in our institution between 1985 and 1998, we retrospectively analyzed 80 cases (53 men, 27 women; mean age, 51 +/- 16 years) in which the nontumoral liver showed no (n = 28) or minimal (n = 52) portal fibrosis without any septal fibrosis. In the group with no portal fibrosis there was no male predominance, and patients were significantly younger (44 +/- 19 years vs. 54 +/- 14 years) than those with minimal portal fibrosis. Sixty-seven tumors were typical HCCs, 8 were of fibrolamellar type, and 5 were hepatocholangiocarcinomas. Mean tumor size was 10 +/- 5 cm. Risk factors for HCC development were found in 30 patients: hepatitis B (n = 17) or C (n = 2) virus infections, alcohol consumption (n = 11), and hemochromatosis (n = 1). In the nontumoral liver, periportal and lobular necrosis, mild portal inflammation, steatosis, and iron overload were present in 15%, 57%, 52%, and 54% of cases, respectively. Liver cell changes were noted in 6%. This study emphasizes the need for strict criteria to classify HCC without cirrhosis. HCC in nonfibrotic liver is a distinct subgroup in which nontumoral liver shows nonspecific minimal changes without regeneration or premalignant lesion. Etiologic factors are often unidentified, although presence of HBV infection in 21% suggests a direct oncogenic role of this virus.

Entities:  

Mesh:

Year:  2000        PMID: 10915724     DOI: 10.1053/jhep.2000.9033

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  55 in total

1.  Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Authors:  Jason Samarasena; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 2.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

3.  Liver resection for hepatocellular carcinoma ≥5 cm.

Authors:  Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Marco Colasanti; Gianluca Mascianà; Edoardo de Werra; Roberto Santoro; Pasquale Lepiane; Marzia Montalbano; Mario Antonini; Giovanni Vennarecci
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-24

4.  A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.

Authors:  Jean C Emond; Benjamin Samstein; John F Renz
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

5.  Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

Authors:  Katsutoshi Tokushige; Etsuko Hashimoto; Yoshinori Horie; Makiko Taniai; Susumu Higuchi
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

Review 6.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

Review 7.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

Review 8.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

10.  Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.

Authors:  Chih-Wen Lin; Chia-Chang Hsu; Hong-Cheng Chang; Yu-Chiun Sun; Po-Lin Sun; Chuan-Yan Hsu; Daw-Shyong Perng
Journal:  Cases J       Date:  2009-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.